These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38219395)

  • 1. Moving urate-lowering therapy in gout beyond guideline recommendations.
    Stamp LK; Dalbeth N
    Semin Arthritis Rheum; 2024 Apr; 65():152358. PubMed ID: 38219395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of serum urate targets in the management of gout.
    Stamp LK; Dalbeth N
    Nat Rev Rheumatol; 2022 Oct; 18(10):603-609. PubMed ID: 35974164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial.
    Peeters IR; den Broeder AA; Taylor WJ; den Broeder N; Flendrie M; van Herwaarden N
    Trials; 2023 Apr; 24(1):282. PubMed ID: 37072799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is the Evidence for Treat-to-Target Serum Urate in Gout?
    Bursill D; Dalbeth N
    Curr Rheumatol Rep; 2018 Mar; 20(3):11. PubMed ID: 29516287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
    Janssen CA; Jansen TLTA; Oude Voshaar MAH; Vonkeman HE; van de Laar MAFJ
    Rheumatol Int; 2017 Sep; 37(9):1435-1440. PubMed ID: 28748426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global patterns of treat-to-serum urate target care for gout: Systematic review and meta-analysis.
    Son CN; Stewart S; Su I; Mihov B; Gamble G; Dalbeth N
    Semin Arthritis Rheum; 2021 Aug; 51(4):677-684. PubMed ID: 34139520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy.
    Pascart T; Latourte A; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):395-404. PubMed ID: 32422338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic gout: Barriers to effective management.
    Rogenmoser S; Arnold MH
    Aust J Gen Pract; 2018 Jun; 47(6):351-356. PubMed ID: 29966174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry.
    Hammam N; Li J; Kay J; Izadi Z; Yazdany J; Schmajuk G
    Arthritis Care Res (Hoboken); 2023 Jul; 75(7):1544-1552. PubMed ID: 36039961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
    Corbett EJM; Pentony P; McGill NW
    Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons and pitfalls from the 2020 Gout Clinical Practice Guideline presented in Atlanta at the ACR 2019.
    Jansen TL; Janssen M
    Clin Rheumatol; 2020 Jun; 39(6):2011-2016. PubMed ID: 32318971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).
    Dalbeth N; Bardin T; Doherty M; Lioté F; Richette P; Saag KG; So AK; Stamp LK; Choi HK; Terkeltaub R
    Nat Rev Rheumatol; 2017 Sep; 13(9):561-568. PubMed ID: 28794514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
    George M; Pullman-Mooar S; Hussain F; Schumacher HR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of gout by UK rheumatologists: a British Society for Rheumatology national audit.
    Roddy E; Packham J; Obrenovic K; Rivett A; Ledingham JM
    Rheumatology (Oxford); 2018 May; 57(5):826-830. PubMed ID: 29447370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we asking the right questions about urate-lowering therapy? Comment on the 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout.
    Jatuworapruk K; Dalbeth N
    Int J Rheum Dis; 2022 Jun; 25(6):714-715. PubMed ID: 35485609
    [No Abstract]   [Full Text] [Related]  

  • 18. Treat to target in gout.
    Perez-Ruiz F; Moreno-Lledó A; Urionagüena I; Dickson AJ
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i20-i26. PubMed ID: 29272512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.
    Hughes JC; Wallace JL; Bryant CL; Salvig BE; Fourakre TN; Stone WJ
    Ann Pharmacother; 2017 Apr; 51(4):301-306. PubMed ID: 27881692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hong Kong Society of Rheumatology consensus recommendations for the management of gout.
    Yip RM; Cheung TT; So H; Chan JP; Ho CT; Tsang HH; Yu CK; Wong PC;
    Clin Rheumatol; 2023 Aug; 42(8):2013-2027. PubMed ID: 37014501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.